The largest database of trusted experimental protocols

5 protocols using chemiluminescence reagent

1

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed by RIPA buffer supplemented with protease inhibitor. The proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were incubated with primary antibodies, then with horseradish peroxidase (HRP)-conjugated secondary antibodies, and visualized by chemiluminescence reagent (Proteintech, Wuhan, Shanghai). The primary antibodies used included antibodies produced by Abcam (Cambridge, MA, USA): anti-osterix, anti-ALP, and anti-osteopontin (OPN); antibodies by Cell Signaling Technology (Danvers, MA, USA): anti-PPARγ, anti-C/EBPα, anti-phospho-src homology 2 domain-containing transforming protein C1 (SHC1) (Tyr317), anti-ERK1/2, and anti-phospho-ERK1/2 (Thr202/Tyr204); antibody by ABclonal (Wuhan, China): anti-nuclear factor of activated T cells 1 (NFATC1); antibody by Beyotime (Shanghai, China): anti-cathepsin K (CTSK); antibodies by Proteintech (Wuhan, China): anti-OSMR, anti-fatty acid-binding protein 4 (FABP4), anti-microtubule-associated protein 1 light chain 3 (LC3), anti-autophagy-related gene 5 (ATG5), anti-autophagy-related gene 7 (ATG7), anti-Beclin 1, anti-P62, anti-SHC1, and anti-β-actin. The expression levels of the target genes were analyzed by dividing the grayscale of the target bands with that of β-actin.
+ Open protocol
+ Expand
2

Western Blotting Procedure for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was conducted as described before 28 (link). In brief, RIPA buffer (APPLYGEN, China) containing 1% protease/phosphatase inhibitor was used for protein extraction. Then 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and polyvinylidene difluoride (PVDF) membranes were used to separate and transfer proteins. Then the membranes were subjected to primary antibodies incubation after blocking with 5% milk. Primary antibodies against ZFP91 were purchased from Abcam and β-actin antibodies were purchased from Proteintech. Followed by an hour incubation with secondary antibodies, the bands were observed by the chemiluminescence reagent (Proteintech).
+ Open protocol
+ Expand
3

Protein Expression Analysis of Cell Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissues and cells were subjected to protein isolation after lysis in RIPA buffer (Applygen Tech Inc., China) containing 1% protease/phosphatase inhibitor. Then, a 10% ExpressCast PAGE Gel Preparation Kit (New Cell and Molecular Biotech, China) was used to separate the proteins. The polyvinylidene difluoride membranes were used for proteins transfer, and the membranes were then blocked with 5% milk. Subsequently, antibodies against LRP8 (NB100-2216, Novus Biologicals, USA), GAPDH (60,004-1-Ig; Proteintech, USA), β-catenin (8480s, Cell Signaling Technology, USA), c-Myc (5605s, Cell Signaling Technology), cyclin D1 (2978s, Cell Signaling Technology), E-cadherin (ab1416; Abcam), N-cadherin (ab98952, Abcam), and vimentin (5741s, Cell Signaling Technology) were used to incubate the membranes overnight. The bands were observed and analyzed using the chemiluminescence reagent (Proteintech) after 1 h incubation with the corresponding secondary antibodies (Proteintech).
+ Open protocol
+ Expand
4

Protein Expression Analysis of Stem Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total proteins were extracted using RIPA lysis buffer and protein concentration was measured using a BCA assay kit (Beyotime). About 30 μg proteins were separated by SDS‐PAGE and then transferred onto nitrocellulose membranes. After blocking with 5% non‐fat milk, the membranes were incubated sequentially with primary antibodies and horseradish peroxidase (HRP)‐conjugated secondary antibodies. The primary antibodies used included antibodies by Abcam: anti‐low‐density lipoprotein receptor‐related protein 6 (LRP6) (ab134146), anti‐ALP (ab108337), and anti‐osterix (ab94744); antibodies by Cell Signalling Technology: anti‐PPARγ (#2443), anti‐C/EBPα (#8178); anti‐Runx2 (#12556), anti‐phospho‐LRP6 (S1490) (#2568), anti‐non‐phospho‐β‐catenin (#8814), anti‐phospho‐GSK3β (S9) (#5558), anti‐phospho‐Smad1/5(S463/465) (#9516) and anti‐GSK3β (#12456); antibodies by Abclonal: anti‐Smad5 (A1947); antibodies by Proteintech: anti‐Smad1 (10429‐1‐AP); anti‐β‐catenin (51067‐2‐AP), anti‐osteopontin (25715‐1‐AP); anti‐fatty acid binding protein 4 (FABP4) (12802‐1‐AP), and anti‐β‐actin (66009‐1‐Ig). The bands were visualized by chemiluminescence reagent (Proteintech). The relative expression levels of the target genes were calculated by dividing the intensity of the target genes by that of β‐actin.
+ Open protocol
+ Expand
5

Western Blot Analysis of Osteogenic Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extracts were run on 10–15% SDS–polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose membranes. After blocking with 5% skim milk, the membranes were probed with primary antibodies, afterwards incubated with horseradish peroxidase-conjugated secondary antibodies. Finally, the bands were visualized using a chemiluminescence reagent (Proteintech, Wuhan, China). The primary antibodies included antibodies from Cell Signaling Technology (Danvers, MA, USA): anti-Runx2 (#12,556), anti-phospho-LRP6 (Ser1490) (#2568), anti-non-phospho-β-catenin (#8814), anti-C/EBPα (#8178), and anti-PPARγ (#2443); antibodies from Abcam (Cambridge, MA, USA): anti-NDRG1 (ab124689), anti-osterix (ab94744), anti-LRP6 (ab134146), anti-transcription factor 7 like 2 (TCF7L2) (ab76151), and anti-alkaline phosphatase (ALP) (ab108337); antibodies from Proteintech (Wuhan, China): anti-fatty acid binding protein 4 (FABP4) (12802-1-AP), anti-osteopontin (25715-1-AP), anti-β-catenin (51067-2-AP), and anti-β-actin (66009-1-Ig).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!